Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation
Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation: an Observational Cohort Study
調査の概要
詳細な説明
DESIGN: An observation cohort study conducted in a tertiary hospital.
METHODS: Data will be collected from patients along the ICU-hospital discharge continuum, will be analysed and non-parametric tests will be used to explore association between variables.
Outcome measures: Muscle strength, as a component of physical function, will be evaluated with the Medical Research Council sum score (MRC- SS) at discharge from ICU and at hospital discharge; the Functional Status Score for the ICU (FSS-ICU) will also be assessed at hospital discharge. Data on participants' demographics, ICU admission and hospital admission will also be collected.
SIGNIFICANCE OF THE RESEARCH: Understanding how physical function is affected in patients with severe COVID-19 may help develop future prevention, therapeutic and follow-up strategies that improve quality of care and outcomes in this specific group of patients. Findings from this study may be useful to design future larger cohort studies and experimental trials.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
-
Madrid、スペイン、28034
- Medical ICU. Hospital Universitario Ramón y Cajal
-
Madrid、スペイン、28034
- Surgical ICU. Hospital Universitario Ramón y Cajal
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- subjects diagnosed with COVID-19 who have required admission to ICU for invasive mechanical ventilation;
- have received invasive ventilation > 24 hours;
- have been successfully weaned from mechanical ventilation > 48 hours;
- were independently able to mobilise prior to current hospital admission (this includes subjects who used a walking stick or another gait aid to mobilise.
Exclusion Criteria:
- subjects or proxies with inability to communicate in Spanish fluently;
- cognitive impairment prior to ICU admission;
- proven neurological impairment or neuromuscular disorder;
- Cerebrovascular Accident during hospital stay;
- previous organ transplant;
- pregnancy;
- unstable fractures or any other injuries that would require medical bed rest.
研究計画
研究はどのように設計されていますか?
デザインの詳細
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Medical Research Council sum score (MRC- SS).
時間枠:< 48 hours before ICU discharge
|
Physical examination will be performed to carry out manual muscle testing of strength in 6 different muscle groups of the upper limb and lower limb on both sides of the body.
|
< 48 hours before ICU discharge
|
|
Medical Research Council sum score (MRC- SS).
時間枠:< 24 hours before hospital discharge
|
Physical examination will be performed to carry out manual muscle testing of strength in 6 different muscle groups of the upper limb and lower limb on both sides of the body.
|
< 24 hours before hospital discharge
|
|
The Functional Status Score for the ICU (FSS-ICU)
時間枠:< 24 hours before hospital discharge
|
The Functional Status Score for the ICU (FSS-ICU) will be used to evaluate 5 functional tasks.
Each task is evaluated using an 8-point ordinal scale ranging from 0 (not able to perform) to 7 (complete independence).The total FSS-ICU score ranges from 0 to 35, with higher scores indicating better physical functioning.
|
< 24 hours before hospital discharge
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Age
時間枠:Through study completion, up to 6 months
|
Age in years
|
Through study completion, up to 6 months
|
|
Sex
時間枠:Throughout study completion , up to 6 month
|
Male vs Female
|
Throughout study completion , up to 6 month
|
|
Body Mass Index
時間枠:Throughout study completion, up to 6 months
|
kg/m2
|
Throughout study completion, up to 6 months
|
|
Baseline mobility
時間枠:First day the patient can cooperate with assessment according to the ' 5 Standard Questions' test.
|
Baseline mobility
|
First day the patient can cooperate with assessment according to the ' 5 Standard Questions' test.
|
|
APACHE II score
時間枠:<24 hours after ICU admission
|
Acute Physiology and Chronic Health Evaluation II score.The APACHE II score ranges from 0 to 71 points.
Higher scores correspond to more severe disease and a higher risk of death.
|
<24 hours after ICU admission
|
|
Length of stay in ICU
時間枠:Throughout the study completion, up to 6 months
|
Number of days of stay in ICU
|
Throughout the study completion, up to 6 months
|
|
Number of days on mechanical ventilation
時間枠:Throughout the study completion, up to 6 months
|
Number of days on mechanical ventilation
|
Throughout the study completion, up to 6 months
|
|
Polyneuropathy diagnosis
時間枠:Throughout the study completion, up to 6 months
|
Clinical or EMG polyneuropathy diagnosis confirmation
|
Throughout the study completion, up to 6 months
|
|
Number of days on Neuromuscular Blockers
時間枠:Throughout the study completion, up to 6 months
|
Number of days on NMB during mechanical ventilation
|
Throughout the study completion, up to 6 months
|
|
Episodes of prone positioning
時間枠:Throughout the study completion, up to 6 months
|
Number of prone positioning episodes during ICU stay
|
Throughout the study completion, up to 6 months
|
|
Length of stay in hospital
時間枠:Throughout the study completion, up to 6 months
|
Total number of days admitted to hospital
|
Throughout the study completion, up to 6 months
|
|
Continuation of care
時間枠:Throughout the study completion, up to 6 months
|
Home with no follow-up physiotherapy, home with domiciliary or out-patient physiotherapy, rehabilitation facility, care home, transfer to another acute hospital.
|
Throughout the study completion, up to 6 months
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 165/20
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
COVID-19(新型コロナウイルス感染症)の臨床試験
-
Pfizer積極的、募集していないCOVID-19(新型コロナウイルス感染症) | コロナウイルス病 2019 (COVID-19) | COVID-19 感染 | COVID-19 ワクチン | SARS-CoV-2 感染、COVID19 | COVID-19 ワクチン接種 | SARS-CoV-2 感染、COVID-19 | COVID-19 (コロナウイルス病 2019) | COVID-19 SARS-CoV-2 感染症アメリカ
-
Pfizer募集気道疾患 | COVID-19(新型コロナウイルス感染症) | 肺炎 | 肺疾患 | コロナウイルス 病気 2019年 | コロナウイルス病 2019 (COVID-19) | COVID-19 感染 | 上気道感染症 | 気道感染症 | COVID-19 (コロナウイルス病 2019) | COVID-19 SARS-CoV-2 感染症ベルギー
-
ModeX Therapeutics, An OPKO Health Company募集
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)完了
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)募集COVID-19 後の状態 | COVID-19 後 | COVID-19 後症候群 | 長い COVID-19 症候群 | COVID-19 後の状態 (PCC)ドイツ
-
Indonesia University募集COVID-19後症候群 | 長い COVID | COVID-19 後の状態 | COVID後症候群 | 長い COVID-19インドネシア
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, Indonesia募集COVID-19 パンデミック | COVID-19 ワクチン | COVID-19 ウイルス病インドネシア
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)積極的、募集していない
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and Development; Post Covid Netwerk...募集